Effects of low-dose scopolamine on locomotor activity: No dissociation between cognitive and non-cognitive effects

Neuroscience Research Communications

Volumn 31, Issue 3, 2002, Pages 165-174

  Gholamreza, Poorheidari ^a   Pratt, Judith A ^b   Nima, Dehghani ^c,d  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Circular box method (automated open field); Closed platform; Locomotor activity; Rat; Scopolamine hydrobromide (HBr); Scopolamine methylbromide (MeBr)

Indexed keywords

SCOPOLAMINE BROMIDE; SCOPOLAMINE METHYL BROMIDE; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; COGNITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; INFRARED RADIATION; LOCOMOTION; MALE; MEMORY DISORDER; NEUROPHARMACOLOGY; NONHUMAN; OPEN FIELD BEHAVIOR; RAT; RAT STRAIN;

EID: 0036872079     PISSN: 08936609     EISSN: None     Source Type: Journal    
DOI: 10.1002/nrc.10049     Document Type: Article

References (42)

1. Davies P. A critical review of the role of the cholinergic system in human memory and cognition. Ann N Y Acad Sci, 1985; 444: 212-217.
2. Bartus RT, Dean RL, Pontecorvo MJ, Flicker C. The cholinergic hypothesis: A historical overview, current perspective, and future directions. Ann N Y Acad Sci, 1985; 444: 332-358.
3. Collerton D. Cholinergic function and intellectual decline in Alzheimer's Disease. Neuroscience, 1986; 19: 1-28.
4. Wirsching BA, Beninger RJ, Jhamandas K, Biegman RJ, El-Defrawy SR. Differential effects of scopolamine on working and reference memory of rats in the radial maze. Pharmacol Biochem Behav, 1984; 20: 659-662.
5. Beatty WW & Bierley RA. Scopolamine degrades spatial working memory but spares spatial reference memory: Dissimilarity of anticholinergic effect and restriction of distal visual cues. Pharmacol Biochem Behav, 1985; 23: 1-6.
6. Okaichi H, Oshima Y, Jarrard LE. Scopolamine impairs both working and reference memory in rats: A replication and extension. Pharmacol Biochem Behav, 1989; 34: 599-602.
7. Jones DNC & Higgins GA. Effect of scopolamine on visual attention in rats. Psychopharmacology, 1995; 120: 142-149.
8. Campbell BA, Lytle LD, Fibiger HC. Ontogeny of adrenergic arousal and cholinergic inhibitory mechanisms in the rat. Science, 1969; 166: 637-638.
9. Thornburg JE & Moore KE. Inhibition of anticholinergic drug-induced locomotor stimulation in mice by α-methyltyrosine. Neuropharmacology, 1973; 12: 1179-1185.
10. Russell RW, Ehlert FJ, Hwa JJ. Relation between behaviorally augmented tolerance and upregulation of muscarinic receptors in the CNS: Effects of chronic administration of scopolamine. Psychopharmacology, 1986; 88: 33-39.
11. Rodgers RJ & Cole JC. Effects of scopolamine and its quaternary analogue in the murine elevated plus-maze test of anxiety. Behav Pharmacol, 1995; 6: 283-289.
12. Ennaceur A & Meliani K. Effects of physostigmine and scopolamine on rats' performances in object-recognition and radial-maze tests. Psychopharmacology, 1992; 109: 321-330.
13. Magnani M, Pozzi O, Biagetti R, Banfi S, Dorigotti L. Oxiracetam antagonises the disruptive effects of scopolamine on memory in the radial maze. Psychopharmacology, 1992; 106: 175-178.
14. Thor DH & Holloway WR, Jr. Scopolamine blocks play fighting behavior in juvenile rats. Physiol Behav, 1983; 30: 545-549.
15. Voytko ML. Cognitive functions of the basal forebrain cholinergic system in monkeys: Memory or attention?. Behavioural Brain Research, 1996; 75: 13-25.
16. Hagan JJ & Morris RGM. The cholinergic hypothesis of memory: A review of animal experiments. In Handbook of psychopharmacology, Eds. Iversen, L.L., Iversen, S.D. and Snyder S.H. Plenum Press, NewYork. 1988; Vol 20: 237-323.
17. Bjokland A. Acetylcholine: A neurotransmitter for learning and memory?. Brain Res Rev, 1996; 21: 285-300.
18. Dennes RP & Barnes JC. Attenuation of scopolamine-induced spatial memory deficits in the rat by cholinomimetic and non-cholinomimetic drugs using a novel task in the 12-arm radial maze. Psychopharmacology, 1993; 111: 435-441.
19. Poorheidari G, Stanhope KJ, Pratt JA. Effects of the potassium channel blockers, apamine and 4-aminopyridine, on scopolamine-induced deficits in the delayed matching to position task in rats: a comparison with the cholinesterase inhibitior E2020. Pschopharmacology. 1998; 135: 242-235
20. Beech M, Hell C, Nightingale P. Central anticholinergic syndrome. Lancet, 1987; 1: 1089.
21. Boeden G & Schmucker P. The central anticholinergic syndrome. Anasthesiologie und Intensivmedizin, 1985; 26: 240-248.
22. Torline RL. Central anticholinergic syndrome: The forgotten diagnosis?. Anesthesiol Rev, 1993; 20: 47-50.
23. Yeomans JS. Role of tegmental cholinergic neurons in dopaminergic activation, antimuscarinic psychosis and schizophrenia. Neuropsychopharmacol, 1995; 12: 3-16.
24. Levin ED. Psychopharmacological effects in the radial-arm maze. Neurosci Biobehav Rev, 1988; 12: 169-175.
25. Renner MJ, Dodson DL, Leduc PA. Scopolamine suppresses both locomotion and object contact in a free-exploration situation. Pharmacol Biochem Behav; 1992; 41(3):625-36
26. Watson CD, Hewitt MJ, Fone KCF, Dickinson SL & Bennett GW. Behavioural effects of scopolamine and the TRH analogue RX77368 on radial arm maze performance in the rat. J Psychopharmacol, 1994; 8: 88-93.
27. Erb C, Troost J, Kopf S, Schmitt U, Loffelholz K, Soreq H & Klein J. Compensatory mechanisms enhance hippocampal acetylcholine release in transgenic mice expressing human acetylcholinesterase. J Neurochem. 2001; 77(2):638-646.
28. Martin JR, Overstreet DH, Driscoll P, Battig K. Effects of scopolamine, pilocarpine, and oxotremorine on the exploratory behavior of two psychogenetically selected lines of rats in a complex maze. Psychopharmacology (Berl); 1981; 72(2):135-42
29. Fitzgerald RE, Berres M, Schaeppi U. Validation of a radial maze test for assessing learning and memory in rats. Toxicology. 1988; 49(2-3):425-32.
30. Stemmelin J, Cassel JC, Will B, Kelche C. Sensitivity to cholinergic drug treatments of aged rats with variable degrees of spatial memory impairment. Behav Brain Res. 1999; 98(1):53-66.
31. Brambilla A, Ghiorzi A, Pitsikas N, Borsini F. DAU 6215, a novel 5-HT3-receptor antagonist, selectively antagonizes scopolamine-induced deficit in a passive-avoidance task, but not scopolamine-induced hypermotility in rats. J Pharmacy & Pharmacol. 1993; 45(9): 841-3.
32. Fontana DJ, Inouye GT, Johonson RM. Linopirdine (DuP 996) improves performance in several tests of learning and memory by modulation of cholinergic neurotransmission. Pharmacol Biochem Behav. 1994; 49(4): 1075-82.
33. Nowakowska E, Chodera A, Kus K. Behavioral and memory improving effects of mirtazapine in rats. Pol J Pharmacol 1999; Nov-Dec;51(6):463-9.
34. Burfani M, Castellano C, Marta M, Oliviero A, Pagella PG, Pavone F, Pomponi M, Rugarli PL. A long-lasting cholinesterase inhibitor affecting neural and behavioral processes. Pharmacol Biochem Behav. 1987; 26(3): 625-9.
35. Eguchi J, Yuasa T, Egawa M, Tobe A. Effects of a novel compound MCI-225 on impaired learning and memory in rats. Pharmacol Biochem Behav. 1994; 48(2): 345-9.
36. Bushnell PJ. Modelling working and reference memory in rats: effects of scopolamine on delayed matching-to-position. Behav Pharmacol, 1990; 1: 419-427.
37. Dodart JC, Mathis C, Ungerer A. Scopolamine-induced deficits in a two-trial object recognition task in mice. Neuroreport, 1997; Mar 24;8(5): 1173-8.
38. Heise GA, Harbrich B, Lilie NL, Martin RA. Scopolamine effects on delayed spatial alternation. Pharmacol Biochem Behav, 1975; 3: 993-1002.
39. Herremans AHJ, Hizjen TH, Olivier B, Slangen JL. Cholinergic drugs effects on a delayed conditional discrimination task in the rat. Behav Neurosci 1995; 109: 426-435.
40. Kirkby DL, Jones DNC, Higgins GA. Influence of prefeeding and scopolamine upon performance in a delayed matching-to-position task. Behav Brain Res, 1995; 67: 221-227.
41. Spencer DG, Pontecorvo MJ, Heise GA. Central cholinergic involvement in working memory: Effects of scopolamine on continuous non-matching and discrimination performance in the rat. Behav Neurosci 1985; 99: 1049-1065.
42. Stanhope KJ, McLenachan AP, Dourish CT. Dissociation between cognitive and motor/motivational deficits in the delayed matching to position test: effects of scopolamine, 8-OH-DPAT and EAA antagonists. Psychopharmacology, 1995; 122: 268-280.